Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NATURETIN-2.5

BENDROFLUMETHIAZIDE

Standard Dose
2.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NATURETIN-2.5 is listed in Drugs@FDA under application 012164 (NDA).

Marketing status: Discontinued Active ingredient BENDROFLUMETHIAZIDE Form and strength TABLET;ORAL - 2.5MG Sponsor APOTHECON Submission history Latest submission status date: 2009-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview NATURETIN-2.5 is listed in Drugs@FDA under application 012164 (NDA). Marketing status: Discontinued Active ingredient BENDROFLUMETHIAZIDE Form and strength TABLET;ORAL - 2.5MG Sponsor APOTHECON Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
NATURETIN-2.5 (BENDROFLUMETHIAZIDE) | Drug Monograph | MedicHelpline